1. IP cisplatin in patients with malignant ascites: Pharmacokinetic evaluation and comparison with the IV route;Casper;Cancer Treat. Rep.,1983
2. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer;Dedrich;Cancer Treat. Rep.,1978
3. Heat sensitization to cisplatin in two cell lines with different drug sensitivity;Eichholtz-Wirth;Int. J. Hyperther.,1990
4. Pharmacokinetics;Gibaldi,1982
5. Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancer;Hacker;Obst. Gyn.,1987